DIMA Biotechnology
DIMA Biotechnology is a biotech company specializing in monoclonal antibody discovery, membrane protein expression, and preclinical R&D solutions for biopharma drug development
Overview
DIMA Biotechnology is a biotechnology company focused on preclinical research and development solutions for the biopharmaceutical industry, particularly in immune oncology and antibody drug discovery. The company develops recombinant monoclonal antibodies and functional proteins using advanced mammalian expression systems, ensuring high biological activity and native protein conformation. DIMA’s core strength lies in its proprietary antibody discovery platforms, such as single B-cell cloning and high-throughput screening technologies, which enable rapid identification of high-affinity antibody candidates. In addition to catalog products, DIMA offers CRO-style services, including antibody engineering, protein production, and preclinical evaluation, helping pharmaceutical companies accelerate drug development pipelines.
Key techniques
DIMA supports advanced antibody discovery and protein engineering workflows used in biopharmaceutical research
Product lines
1,500+ recombinant proteins produced using mammalian expression systems
Antibodies ›
Capabilities
DIMA integrates antibody discovery platforms, protein engineering, and preclinical evaluation systems to accelerate biologics development
QC & documentation
DIMA provides detailed technical and validation data for antibodies, proteins, and preclinical services
Lead time & shipping
Timelines vary depending on product availability and project scope